{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T11:01:08Z","timestamp":1758970868857},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,6,5]],"date-time":"2015-06-05T00:00:00Z","timestamp":1433462400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s00415-015-7788-2","type":"journal-article","created":{"date-parts":[[2015,6,4]],"date-time":"2015-06-04T11:04:29Z","timestamp":1433415869000},"page":"1927-1935","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Cerebellar neurochemical alterations in spinocerebellar ataxia type 14 appear to include glutathione deficiency"],"prefix":"10.1007","volume":"262","author":[{"given":"Sarah","family":"Doss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan Leo","family":"Rinnenthal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanja","family":"Schmitz-H\u00fcbsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander U.","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Papazoglou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silke","family":"Lux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Maul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"W\u00fcrfel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Endres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Klockgether","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Minnerop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Friedemann","family":"Paul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,6,5]]},"reference":[{"key":"7788_CR1","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1086\/373883","volume":"72","author":"D-H Chen","year":"2003","unstructured":"Chen D-H, Brkanac Z, Verlinde CLMJ et al (2003) Missense mutations in the regulatory domain of pkc: a new mechanism for dominant nonepisodic cerebellar ataxia. Am J Hum Genet 72:839\u2013849","journal-title":"Am J Hum Genet"},{"key":"7788_CR2","doi-asserted-by":"crossref","first-page":"29096","DOI":"10.1074\/jbc.M501716200","volume":"280","author":"T Seki","year":"2005","unstructured":"Seki T, Adachi N, Ono Y et al (2005) Mutant protein kinase Cgamma found in spinocerebellar ataxia type 14 is susceptible to aggregation and causes cell death. J Biol Chem 280:29096\u201329106. doi: 10.1074\/jbc.M501716200","journal-title":"J Biol Chem"},{"key":"7788_CR3","doi-asserted-by":"crossref","first-page":"14324","DOI":"10.1523\/JNEUROSCI.5530-10.2011","volume":"31","author":"AN Shuvaev","year":"2011","unstructured":"Shuvaev AN, Horiuchi H, Seki T et al (2011) Mutant PKC\u03b3 in spinocerebellar ataxia type 14 disrupts synapse elimination and long-term depression in Purkinje cells in vivo. J Neurosci 31:14324\u201314334. doi: 10.1523\/JNEUROSCI.5530-10.2011","journal-title":"J Neurosci"},{"key":"7788_CR4","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1212\/01.WNL.0000156801.64549.6B","volume":"64","author":"D-H Chen","year":"2005","unstructured":"Chen D-H, Cimino PJ, Ranum LPW et al (2005) The clinical and genetic spectrum of spinocerebellar ataxia 14. Neurology 64:1258\u20131260. doi: 10.1212\/01.WNL.0000156801.64549.6B","journal-title":"Neurology"},{"key":"7788_CR5","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1212\/01.WNL.0000098883.79421.73","volume":"61","author":"BPC Warrenburg van de","year":"2003","unstructured":"van de Warrenburg BPC, Verbeek DS, Piersma SJ et al (2003) Identification of a novel SCA14 mutation in a Dutch autosomal dominant cerebellar ataxia family. Neurology 61:1760\u20131765. doi: 10.1212\/01.WNL.0000098883.79421.73","journal-title":"Neurology"},{"key":"7788_CR6","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/mds.20851","volume":"21","author":"MHM Vlak","year":"2006","unstructured":"Vlak MHM, Sinke RJ, Rabelink GM et al (2006) Novel PRKCG\/SCA14 mutation in a Dutch spinocerebellar ataxia family: expanding the phenotype. Mov Disord 21:1025\u20131028. doi: 10.1002\/mds.20851","journal-title":"Mov Disord"},{"key":"7788_CR7","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1002\/mds.21673","volume":"22","author":"S Wieczorek","year":"2007","unstructured":"Wieczorek S, Arning L, Gizewski ER et al (2007) Benign SCA14 phenotype in a German patient associated with a missense mutation in exon 3 of the PRKCG gene. Mov Disord 22:2135\u20132136. doi: 10.1002\/mds.21673","journal-title":"Mov Disord"},{"key":"7788_CR8","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1600-0404.2011.01504.x","volume":"125","author":"J Koht","year":"2012","unstructured":"Koht J, Stevanin G, Durr A et al (2012) SCA14 in Norway, two families with autosomal dominant cerebellar ataxia and a novel mutation in the PRKCG gene. Acta Neurol Scand 125:116\u2013122. doi: 10.1111\/j.1600-0404.2011.01504.x","journal-title":"Acta Neurol Scand"},{"key":"7788_CR9","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/1471-2377-13-186","volume":"13","author":"IM Wedding","year":"2013","unstructured":"Wedding IM, Koht J, Dietrichs E et al (2013) Cognition is only minimally impaired in Spinocerebellar ataxia type 14 (SCA14): a neuropsychological study of ten Norwegian subjects compared to intrafamilial controls and population norm. BMC Neurol 13:186. doi: 10.1186\/1471-2377-13-186","journal-title":"BMC Neurol"},{"key":"7788_CR10","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/ana.20628","volume":"58","author":"S Klebe","year":"2005","unstructured":"Klebe S, Durr A, Rentschler A et al (2005) New mutations in protein kinase Cgamma associated with spinocerebellar ataxia type 14. Ann Neurol 58:720\u2013729. doi: 10.1002\/ana.20628","journal-title":"Ann Neurol"},{"key":"7788_CR11","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1002\/mds.20970","volume":"21","author":"K Hiramoto","year":"2006","unstructured":"Hiramoto K, Kawakami H, Inoue K et al (2006) Identification of a new family of spinocerebellar ataxia type 14 in the Japanese spinocerebellar ataxia population by the screening of PRKCG exon 4. Mov Disord 21:1355\u20131360. doi: 10.1002\/mds.20970","journal-title":"Mov Disord"},{"key":"7788_CR12","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.expneurol.2011.09.021","volume":"232","author":"G Oz","year":"2011","unstructured":"Oz G, Vollmers ML, Nelson CD et al (2011) In vivo monitoring of recovery from neurodegeneration in conditional transgenic SCA1 mice. Exp Neurol 232:290\u2013298. doi: 10.1016\/j.expneurol.2011.09.021","journal-title":"Exp Neurol"},{"key":"7788_CR13","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1007\/s00415-013-6998-8","volume":"260","author":"TM Lopes","year":"2013","unstructured":"Lopes TM, D\u2019Abreu A, Fran\u00e7a MC Jr et al (2013) Widespread neuronal damage and cognitive dysfunction in spinocerebellar ataxia type 3. J Neurol 260:2370\u20132379. doi: 10.1007\/s00415-013-6998-8","journal-title":"J Neurol"},{"key":"7788_CR14","doi-asserted-by":"crossref","first-page":"e47925","DOI":"10.1371\/journal.pone.0047925","volume":"7","author":"J-F Lirng","year":"2012","unstructured":"Lirng J-F, Wang P-S, Chen H-C et al (2012) Differences between spinocerebellar ataxias and multiple system atrophy-cerebellar type on proton magnetic resonance spectroscopy. PLoS One 7:e47925. doi: 10.1371\/journal.pone.0047925","journal-title":"PLoS One"},{"key":"7788_CR15","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1600-0404.2011.01620.x","volume":"126","author":"M Hadjivassiliou","year":"2012","unstructured":"Hadjivassiliou M, Wallis LI, Hoggard N et al (2012) MR spectroscopy and atrophy in Gluten, Friedreich\u2019s and SCA6 ataxias. Acta Neurol Scand 126:138\u2013143. doi: 10.1111\/j.1600-0404.2011.01620.x","journal-title":"Acta Neurol Scand"},{"key":"7788_CR16","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/jmri.1078","volume":"13","author":"SM Boesch","year":"2001","unstructured":"Boesch SM, Schocke M, B\u00fcrk K et al (2001) Proton magnetic resonance spectroscopic imaging reveals differences in spinocerebellar ataxia types 2 and 6. J Magn Reson Imaging 13:553\u2013559","journal-title":"J Magn Reson Imaging"},{"key":"7788_CR17","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/jmri.20846","volume":"25","author":"SM Boesch","year":"2007","unstructured":"Boesch SM, Wolf C, Seppi K et al (2007) Differentiation of SCA2 from MSA-C using proton magnetic resonance spectroscopic imaging. J Magn Reson Imaging 25:564\u2013569. doi: 10.1002\/jmri.20846","journal-title":"J Magn Reson Imaging"},{"key":"7788_CR18","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s12311-013-0527-2","volume":"13","author":"S Doss","year":"2014","unstructured":"Doss S, Brandt AU, Oberwahrenbrock T et al (2014) Metabolic Evidence for Cerebral Neurodegeneration in Spinocerebellar Ataxia Type 1. Cerebellum 13:199\u2013206. doi: 10.1007\/s12311-013-0527-2","journal-title":"Cerebellum"},{"key":"7788_CR19","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1002\/mds.23067","volume":"25","author":"G Oz","year":"2010","unstructured":"Oz G, Hutter D, Tk\u00e1c I et al (2010) Neurochemical alterations in spinocerebellar ataxia type 1 and their correlations with clinical status. Mov Disord 25:1253\u20131261. doi: 10.1002\/mds.23067","journal-title":"Mov Disord"},{"key":"7788_CR20","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s12311-010-0213-6","volume":"10","author":"G Oz","year":"2011","unstructured":"Oz G, Iltis I, Hutter D et al (2011) Distinct neurochemical profiles of spinocerebellar ataxias 1, 2, 6, and cerebellar multiple system atrophy. Cerebellum 10:208\u2013217. doi: 10.1007\/s12311-010-0213-6","journal-title":"Cerebellum"},{"key":"7788_CR21","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/gps.1042","volume":"19","author":"E Kalbe","year":"2004","unstructured":"Kalbe E, Kessler J, Calabrese P et al (2004) DemTect: a new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia. Int J Geriatr Psychiatry 19:136\u2013143. doi: 10.1002\/gps.1042","journal-title":"Int J Geriatr Psychiatry"},{"key":"7788_CR22","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1212\/01.wnl.0000219042.60538.92","volume":"66","author":"T Schmitz-H\u00fcbsch","year":"2006","unstructured":"Schmitz-H\u00fcbsch T, du Montcel ST, Baliko L et al (2006) Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology 66:1717\u20131720. doi: 10.1212\/01.wnl.0000219042.60538.92","journal-title":"Neurology"},{"key":"7788_CR23","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s12311-012-0421-3","volume":"12","author":"H Jacobi","year":"2013","unstructured":"Jacobi H, Rakowicz M, Rola R et al (2013) Inventory of Non-Ataxia Signs (INAS): validation of a new clinical assessment instrument. Cerebellum 12:418\u2013428. doi: 10.1007\/s12311-012-0421-3","journal-title":"Cerebellum"},{"key":"7788_CR24","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1212\/01.WNL.0000098883.79421.73","volume":"61","author":"BPC Warrenburg van de","year":"2003","unstructured":"van de Warrenburg BPC, Verbeek DS, Piersma SJ et al (2003) Identification of a novel SCA14 mutation in a Dutch autosomal dominant cerebellar ataxia family. Neurology 61:1760\u20131765. doi: 10.1212\/01.WNL.0000098883.79421.73","journal-title":"Neurology"},{"key":"7788_CR25","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1001\/archneur.59.8.1291","volume":"59","author":"Z Brkanac","year":"2002","unstructured":"Brkanac Z, Bylenok L, Fernandez M et al (2002) A new dominant spinocerebellar ataxia linked to chromosome 19q13.4-qter. Arch Neurol 59:1291\u20131295. doi: 10.1001\/archneur.59.8.1291","journal-title":"Arch Neurol"},{"key":"7788_CR26","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/1531-8249(200008)48:2<156::AID-ANA4>3.0.CO;2-9","volume":"48","author":"I Yamashita","year":"2000","unstructured":"Yamashita I, Sasaki H, Yabe I et al (2000) A novel locus for dominant cerebellar ataxia (SCA14) maps to a 10.2-cM interval flanked by D19S206 and D19S605 on chromosome 19q13.4-qter. Ann Neurol 48:156\u2013163","journal-title":"Ann Neurol"},{"key":"7788_CR27","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0304-3940(98)00527-8","volume":"251","author":"RL Tyson","year":"1998","unstructured":"Tyson RL, Sutherland GR (1998) Labeling of N-acetylaspartate and N-acetylaspartylglutamate in rat neocortex, hippocampus and cerebellum from [1-13C]glucose. Neurosci Lett 251:181\u2013184","journal-title":"Neurosci Lett"},{"key":"7788_CR28","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1046\/j.1471-4159.2000.0750443.x","volume":"75","author":"JH Neale","year":"2000","unstructured":"Neale JH, Bzdega T, Wroblewska B (2000) N-Acetylaspartylglutamate: the most abundant peptide neurotransmitter in the mammalian central nervous system. J Neurochem 75:443\u2013452","journal-title":"J Neurochem"},{"key":"7788_CR29","author":"A Groger","year":"2014","unstructured":"Groger A, Kolb R, Schafer R, Klose U (2014) Dopamine reduction in the substantia nigra of parkinson\u2019s disease patients confirmed by in vivo magnetic resonance spectroscopic imaging. PLoS One. doi: 10.1371\/journal.pone.0084081","journal-title":"PLoS One"},{"key":"7788_CR30","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.3390\/nu4101399","volume":"4","author":"WM Johnson","year":"2012","unstructured":"Johnson WM, Wilson-Delfosse AL, Mieyal JJ (2012) Dysregulation of glutathione homeostasis in neurodegenerative diseases. Nutrients 4:1399\u20131440. doi: 10.3390\/nu4101399","journal-title":"Nutrients"},{"key":"7788_CR31","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1750-1172-2-16","volume":"2","author":"E Ristoff","year":"2007","unstructured":"Ristoff E, Larsson A (2007) Inborn errors in the metabolism of glutathione. Orphanet J Rare Dis 2:16. doi: 10.1186\/1750-1172-2-16","journal-title":"Orphanet J Rare Dis"},{"key":"7788_CR32","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.brainres.2010.08.030","volume":"1358","author":"I Iltis","year":"2010","unstructured":"Iltis I, Hutter D, Bushara KO et al (2010) (1)H MR spectroscopy in Friedreich\u2019s ataxia and ataxia with oculomotor apraxia type 2. Brain Res 1358:200\u2013210. doi: 10.1016\/j.brainres.2010.08.030","journal-title":"Brain Res"},{"key":"7788_CR33","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.1242\/jeb.02524","volume":"209","author":"D Lin","year":"2006","unstructured":"Lin D, Barnett M, Lobell S et al (2006) PKCgamma knockout mouse lenses are more susceptible to oxidative stress damage. J Exp Biol 209:4371\u20134378. doi: 10.1242\/jeb.02524","journal-title":"J Exp Biol"},{"key":"7788_CR34","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/WNF.0b013e31829ae713","volume":"36","author":"MJ Holmay","year":"2013","unstructured":"Holmay MJ, Terpstra M, Coles LD et al (2013) N-acetylcysteine boosts brain and blood glutathione in Gaucher and Parkinson diseases. Clin Neuropharmacol 36:103\u2013106. doi: 10.1097\/WNF.0b013e31829ae713","journal-title":"Clin Neuropharmacol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-015-7788-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-015-7788-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-015-7788-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T03:38:16Z","timestamp":1566790696000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-015-7788-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,5]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["7788"],"URL":"https:\/\/doi.org\/10.1007\/s00415-015-7788-2","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,5]]}}}